Sarcoidosis - Cleveland Clinic Center for Continuing Education

More documents

Recommendations

Info

Diagnostic effectiveness of EBUS-TBNA in sarcoidosis Author N Se Sp PPV NPV Prevalence Wong 2007 65 92 100 88 44 98 Oki 2007 15 93 100 100 50 93 Garwood 2007 50 85 100 100 12,5 98 Tremblay 2009 50 83 100 n.a n.a. 92 Nakajima 2009* 38 91 100 100 50 92 *Retrospective study; all other prospective
The spectrum of Bx sites in 736 cases of sarcoidosis participating in ACCESS Biopsy site Number of Biopsies INTRATHORACIC Lung 329 Lymph node 181 Trachea/Bronchi 57 EXTRATHORACIC Skin 74 Lymph node 61 Liver 19 Kveim site 11 Nasopharynx 8 Parotid/Salivary 6 Spleen 6 Other 21 TOTAL 776 Teirstein, 2005
Page 1 and 2:
Sarcoidosis around the world: Past,
Page 3 and 4:
Historical development of sarcoidos
Page 5 and 6:
Sarcoidosis of the skin, described
Page 7:
Sarcoidosis milestones (1) • 1869
Page 10 and 11:
In 1899 Caesar Boeck published his
Page 12 and 13:
Otto Jüngling (1884-1944) Publishe
Page 14 and 15:
Sarcoidosis milestones (2) 1941 A.
Page 16 and 17:
The participants to the 1st Interna
Page 18 and 19:
International Conferences on Sarcoi
Page 20 and 21:
Hot topics of the 10th Internationa
Page 22:
Om P. Sharma Chairman
Page 25:
5th WASOG Meeting Essen 1997
Page 30:
9th WASOG Meeting & 11th BAL Congre
Page 34:
To assess health status and quality
Page 38 and 39:
Contents of SARCOIDOSIS Vol. 1, No.
Page 46 and 47:
Sarcoidosis: Past, Present, Future
Page 48 and 49:
1991 Definition of sarcoidosis incl
Page 50 and 51:
Definition of sarcoidosis • Sarco
Page 52 and 53:
Comparison Finland vs Hokkaido, Jap
Page 54 and 55:
Normalisation of chest x ray over 5
Page 56 and 57:
Page 58 and 59:
HLA-types and Sarcoidosis “Protec
Page 60 and 61:
Resolved (%) Resolution of Löfgren
Page 62 and 63:
Percent of patients Heerfordt´s sy
Page 64 and 65:
What are potential causative agents
Page 66 and 67:
Etiological triggers • Role of my
Page 68 and 69:
Spot forming cells/million PBMC T-c
Page 70 and 71:
Page 72 and 73: Hypercalcemia in Sarcoidosis • 19
Page 74 and 75: Immunology of sarcoidosis: Discrepa
Page 76 and 77: Compartmentalized Immune Response i
Page 78 and 79: Sarcoidosis: Past, Present, Future
Page 80 and 81: Diagnostic approach The diagnosis o
Page 82 and 83: Sarcoidosis: a systemic disease •
Page 84 and 85: Fatigue: a major problem Four types
Page 86 and 87: Measurements: systemic response •
Page 88 and 89: The changing tools for diagnosing s
Page 91 and 92: Mediastinoscopy in patients with pr
Page 93: 33,000 Mediastinoscopies for BHL Co
Page 98 and 99: BAL Profile in Sarcoidosis • Lymp
Page 100 and 101: J. Chrétien C. Voisin Lille, Franc
Page 102 and 103: L. Bjermer T Sandström
Page 104 and 105: C. Burke L. Poulter
Page 106 and 107: ... and his fans
Page 108 and 109: Krakow 7th International BAL Confer
Page 110: Carlos Robalo Cordeiro
Page 113: The changing tools for diagnosing s
Page 116 and 117: The changing tools for diagnosing s
Page 118 and 119: TBNA for Diagnosing Sarcoidosis Aut
Page 120 and 121: Endobronchial Ultrasound in Sarcoid
Page 124 and 125: Per cent biopsy of involved organ #
Page 126 and 127: Clinical Course • ACCESS study: -
Page 128 and 129: Follow-up for sarcoidosis in resear
Page 130 and 131: Sarcoidosis: Past, Present, Future
Page 132 and 133: Treatment for Sarcoidosis • Which
Page 134 and 135: Goal of Treatment • Reduce sympto
Page 136 and 137: Indication for treatment of pulmona
Page 138 and 139: Alternative drugs for sarcoidosis
Page 140 and 141: Biological Agents with anti-TNF Act
Page 142 and 143: Lupus Pernio after 4th dose Inflixi
Page 144 and 145: 6 months therapy with Infliximab po
Page 146 and 147: Active recruiting studies for sarco
Page 148 and 149: Areas of Future Research • Discov
Page 150 and 151: Physiology Future scenario for sarc
Page 152:
WASOG Family
show all

Sarcoidosis - Cleveland Clinic Center for Continuing Education

Create successful ePaper yourself

Delete template?

Save as template?